Genta Incorporated (OTC:GNTA) stock price lost additional 14.41% on Friday and closed the session at $0.0196. At the same time the volume traded was 13.2 million, with the average being 4.9 million.
Price has been steadily going down for GNTA ever since Oct. 11, when they announced that Tesetaxel was granted orphan drug designation for gastric cancer by the European Medicines Agency. That day the price dropped 70.62% with a record volume of 52.8 million shares traded.
Genta Incorporated is a bio-pharmaceutical…